UltraLinq is pleased to announce the acquisition of Cardiostream LLC.
According to Stephen Farber, CEO of UltraLinq, “The decision to acquire Cardiostream is rooted in UltraLinq’s continuing drive to broaden its platform and address patient care issues through the provision of efficient and cost-effective solutions.”
Along with seasoned expertise, the addition will bring added Nuclear functionality to UltraLinq’s existing product. CTO Richard Safran spoke highly with regards to the acquisition; “The team at UltraLinq is thrilled to add the people and products from Cardiostream to our group. We look forward to the new competencies that the combined team will bring to the development of new products and the enhancement of our combined product offerings.”